Related Experiment Videos
[Amaurosis after lachrymo-nasal stent surgery]
A Bracamonte Bermejo1, C Lanciego Pérez
1Hospital Ntra. Sra. del Prado, Talavera de la Reina, Toledo, Spain.
Archivos De La Sociedad Espanola De Oftalmologia
|August 3, 2004
Summary
A case of orbital cellulitis following lachrymal stent placement resulted in vision loss. Prompt treatment improved inflammation but not visual acuity, highlighting potential complications of intraocular devices.
Area of Science:
- Ophthalmology
- Ophthalmic Surgery
Background:
- Lachrymal stents are used to treat nasolacrimal duct obstruction.
- Periocular infections can lead to serious orbital complications.
Observation:
- A 74-year-old woman developed periocular pain and vision loss in her left eye three days after lachrymal stent insertion.
- Despite aggressive treatment, visual acuity deteriorated to no light perception.
Findings:
- The patient was diagnosed with orbital cellulitis, an inflammation of orbital tissues.
- Removal of the lachrymal stent and subsequent dacryocystectomy were performed.
Implications:
- Orbital cellulitis requires urgent and aggressive management to prevent vision loss.
- The potential for intraocular device-associated infections and complications must be considered.